{"product_id":"hioscar-pestle-analysis","title":"Oscar Health PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how regulatory shifts, rising healthcare costs, and tech-driven care models are reshaping Oscar Health’s trajectory—our concise PESTLE highlights the risks and opportunities you need to know; buy the full analysis to access the complete, actionable intelligence and ready-to-use formats for investment or strategy work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAffordable Care Act Subsidy Extensions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe continuation of enhanced premium tax credits through 2025 is a critical driver for Oscar Health, supporting individual-market affordability and contributing to membership growth—Oscar reported 529,000 members on the exchanges in 2024, aided by subsidies that cut average premiums by roughly 60% for eligible enrollees. Legislative moves to make subsidies permanent would stabilize enrollment and revenue; conversely, a rollback could raise premiums, likely increasing churn and reducing membership and ARPU across core exchanges.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eState Exchange Regulatory Variations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOscar Health must navigate a patchwork of state regulations as it expands; 2024 filings show 30+ significant state-level variations in network adequacy and rate-band rules that affect product launches.\u003c\/p\u003e\n\u003cp\u003eState insurance commissioners set specific requirements—e.g., Medicaid expansion states versus non-expansion states—forcing Oscar to adjust pricing and provider contracts, squeezing margins that averaged a 3–5% underwriting loss in some 2023 markets.\u003c\/p\u003e\n\u003cp\u003ePolitical shifts—2024 saw 12 gubernatorial or legislative changes affecting insurance oversight—can abruptly raise market-entry costs or impose new reporting and solvency mandates, increasing regulatory compliance spend per state by an estimated $1–3 million.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFederal Healthcare Policy Shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe post-2024 election landscape in Washington will determine the individual mandate's viability and funding for private-public partnerships that underpin 75% of Oscar Health's 2025 individual-plan revenue projections; repeal or scaling-back could shrink enrollment and ARPU. Changes in HHS leadership could add administrative burdens or streamline telehealth and digital billing processes that affect Oscar's 2024–25 operating margin targets (recent guidance: negative adjusted EBITDA in 2024 improving toward breakeven). Oscar is highly sensitive to federal shifts that prioritize ACA marketplaces, since 60–70% of its membership is through subsidized exchanges.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare Advantage Oversight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpincreased cms scrutiny on medicare advantage reimbursement and marketing constrains oscar health expansion targeted overpayments totaling about billion recovery actions in pressuring plan economics.\u003e\n\u003cpstricter federal rules on star ratings and risk adjustment force oscar to boost compliance data accuracy spending medicare advantage plans saw average star-driven bonuses swing plan revenue by up in\u003e\n\u003cppolitical pressure to curb overpayments may compress margins for oscar specialized ma offerings profit fell near in raising solvency and pricing risk.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCMS recovery ~$15.6B (2023–24)\u003c\/li\u003e\n\u003cli\u003eStar\/risk changes impact revenue 3–5%\u003c\/li\u003e\n\u003cli\u003eMA margins compressed to ~2–4% in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/ppolitical\u003e\u003c\/pstricter\u003e\u003c\/pincreased\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Option Competition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe emergence of state-backed public option pilots in 2024–25, notably California’s proposed public plan targeting a 10–15% premium reduction, raises direct price pressure in Oscar Health’s urban markets where it reported ~$1.2B ACA enrollment premium revenue in 2024.\u003c\/p\u003e\n\u003cp\u003ePublic options, subsidized and with broader risk pools, could undercut Oscar’s pricing and force margin compression; Oscar must demonstrate lower total cost of care and retention of member LTV to compete.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003ePublic option pilots: 2024–25 expansion, estimated 10–15% premium declines\u003c\/li\u003e\n\u003cli\u003eOscar exposure: ~$1.2B ACA premium revenue (2024)\u003c\/li\u003e\n\u003cli\u003eRisk: margin pressure, need to prove superior total cost of care\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOscar at Risk: $15.6B CMS Pressure, Subsidy Rollbacks Threaten Exchange \u0026amp; MA Margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFederal subsidy permanence and CMS actions ( ~$15.6B recoveries 2023–24) heavily influence Oscar’s exchange and MA economics; 529k exchange members and ~$1.2B ACA premium revenue in 2024 make Oscar sensitive to subsidy rollbacks, public-option price cuts (10–15%) and MA margin compression (2–4%), raising compliance and solvency costs across 30+ divergent state regulatory regimes.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/24–25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eExchange members\u003c\/td\u003e\n\u003ctd\u003e529,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eACA premium rev\u003c\/td\u003e\n\u003ctd\u003e$1.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS recoveries\u003c\/td\u003e\n\u003ctd\u003e$15.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic option impact\u003c\/td\u003e\n\u003ctd\u003e-10–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMA margins\u003c\/td\u003e\n\u003ctd\u003e2–4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how macro-environmental forces—Political, Economic, Social, Technological, Environmental, and Legal—uniquely affect Oscar Health, using data-driven trends and regulatory context to highlight risks and growth opportunities for insurers and healthtech.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, visually segmented PESTLE summary for Oscar Health that simplifies external risk and opportunity assessment, ready to drop into presentations or share across teams for quick alignment during strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Cost Inflation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising clinical service and drug prices have pushed US medical cost inflation to roughly 5–8% annually in 2024–25, exerting upward pressure on Oscar Health’s medical loss ratios and contributing to its 2024 GAAP loss; higher provider reimbursement demands amid clinician wage growth force Oscar to balance competitive premiums with margin recovery.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndividual Market Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising gig work—now 36% of US workers in 2024 per JPMorgan Chase Institute—expands the individual insurance TAM as fewer rely on employer plans; Oscar Health’s digital-first platform, which grew individual membership ~22% YoY in 2023, aligns with mobile, tech-savvy contractors. This macro shift offers steady member-acquisition tailwinds outside corporate channels, supporting Oscar’s push into ACA and direct-to-consumer sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Environment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs of late 2025, tightening U.S. rates (Fed funds ~5.25–5.50%) raises Oscar Health’s cost of capital, while boosting yield on invested reserves—Q3 2025 investment yield for insurers averaged ~3.8–4.5%, improving net investment income potential for Oscar’s balance sheet.\u003c\/p\u003e\n\u003cp\u003eHigher rates, however, increase financing costs for large-scale +Oscar R\u0026amp;D and infrastructure, potentially elevating WACC and delaying ROI on tech projects.\u003c\/p\u003e\n\u003cp\u003eStable capital markets remain vital for licensing +Oscar; market volatility in 2024–25—equity market drawdowns ~12–18% in 2024—could constrain partner adoption and deal financing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumer Disposable Income\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eConsumer disposable income and the 3.7% US unemployment rate (Jan 2026) directly affect ability to pay premiums and OOP costs; lower real wages and 2024–25 CPI-driven inflation squeezed household budgets, reducing demand for higher-tier plans.\u003c\/p\u003e\n\u003cp\u003eEconomic volatility leads consumers to downgrade or drop coverage, altering Oscar Health’s revenue mix—Q4 2025 enrollment showed a 4% shift toward lower-premium tiers in some markets.\u003c\/p\u003e\n\u003cp\u003eOscar uses data-driven pricing and risk adjustment models to respond to purchasing-power swings, aiming to protect margin and membership stability.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUnemployment: 3.7% (Jan 2026)\u003c\/li\u003e\n\u003cli\u003eCPI inflation pressure 2024–25 reduced real wages\u003c\/li\u003e\n\u003cli\u003eQ4 2025: ~4% shift to lower-tier plans in key markets\u003c\/li\u003e\n\u003cli\u003eData-driven pricing helps mitigate revenue mix risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor Market for Tech Talent\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe high cost of recruiting and retaining specialized software engineers and data scientists remains a major operational expense for Oscar Health, with US tech median total compensation for senior engineers reaching roughly $200k–$300k in 2024, and data scientists averaging $150k–$220k, inflating hiring budgets and R\u0026amp;D spend.\u003c\/p\u003e\n\u003cp\u003eOscar depends on top-tier technical talent to operate its proprietary full-stack platform and member app; turnover or gaps slow product releases and raise integration costs.\u003c\/p\u003e\n\u003cp\u003eCompetition from big-tech firms—who spent over $300B on R\u0026amp;D in 2024 and offer premium compensation—pushes Oscar’s administrative and recruiting costs higher and can compress time-to-market for innovations.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSenior engineer comp: ~$200k–$300k (2024)\u003c\/li\u003e\n\u003cli\u003eData scientist comp: ~$150k–$220k (2024)\u003c\/li\u003e\n\u003cli\u003eBig-tech R\u0026amp;D spend: \u0026gt;$300B (2024)\u003c\/li\u003e\n\u003cli\u003eHigher hiring costs → slower product delivery\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCost pressures and gig growth squeeze margins as wages and medical inflation climb\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEconomic pressures—medical cost inflation ~5–8% (2024–25), Fed funds ~5.25–5.50% (late 2025), CPI-driven real-wage erosion—raise Oscar’s medical loss ratios and cost of capital while improving investment yields; gig-economy growth (36% workforce, 2024) expands ACA TAM, but consumer downgrades (Q4 2025: ~4% shift to lower-tier plans) compress revenue mix; high tech wages (senior eng $200k–$300k, data sci $150k–$220k, 2024) lift Ops and R\u0026amp;D spend.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical inflation\u003c\/td\u003e\n\u003ctd\u003e5–8% (2024–25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed funds\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50% (late 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGig workforce\u003c\/td\u003e\n\u003ctd\u003e36% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnrollment shift\u003c\/td\u003e\n\u003ctd\u003e~4% to lower tiers (Q4 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSenior eng comp\u003c\/td\u003e\n\u003ctd\u003e$200k–$300k (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eOscar Health PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Oscar Health PESTLE Analysis document you’ll receive after purchase—fully formatted, professionally structured, and ready to use.\u003c\/p\u003e\n\u003cp\u003eNo placeholders or teasers: the content, layout, and insights visible in the preview are the final file you’ll download immediately after payment.\u003c\/p\u003e\n\u003cp\u003eThis is the real product—comprehensive, polished, and delivered exactly as shown.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751394619769,"sku":"hioscar-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/hioscar-pestle-analysis.png?v=1772230878","url":"https:\/\/matrixbcg.com\/products\/hioscar-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}